Are 'omics of estrogen receptors defining potential targets for breast cancer treatment?

被引：0
作者：
Metivier, Raphael [1 ]
机构：
[1] Univ Rennes 1, Equipe SP RTE, Equipe Labellisee Ligue Canc, CNRS,UMR 6026, F-35042 Rennes, France
来源：
EPIGENOMICS | 2011年 / 3卷 / 05期
关键词：
3D chromatin organization; breast cancer; cistromes; estrogen receptor; interactome; transcription; transcriptomes; ER-ALPHA; CELLS; RESISTANCE; GENE; THERAPY; TUMORS;
D O I：
10.2217/EPI.11.81
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：525 / 528
页数：4
相关论文
共 22 条
  • [1] Endocrine-responsive breast cancer and strategies for combating resistance
    Ali, S
    Coombes, RC
    [J]. NATURE REVIEWS CANCER, 2002, 2 (02) : 101 - +
  • [2] Genome-based and transcriptome-based molecular classification of breast cancer
    Bieche, Ivan
    Lidereau, Rosette
    [J]. CURRENT OPINION IN ONCOLOGY, 2011, 23 (01) : 93 - 99
  • [3] Genome-wide analysis of estrogen receptor binding sites
    Carroll, Jason S.
    Meyer, Clifford A.
    Song, Jun
    Li, Wei
    Geistlinger, Timothy R.
    Eeckhoute, Jerome
    Brodsky, Alexander S.
    Keeton, Erika Krasnickas
    Fertuck, Kirsten C.
    Hall, Giles F.
    Wang, Qianben
    Bekiranov, Stefan
    Sementchenko, Victor
    Fox, Edward A.
    Silver, Pamela A.
    Gingeras, Thomas R.
    Liu, X. Shirley
    Brown, Myles
    [J]. NATURE GENETICS, 2006, 38 (11) : 1289 - 1297
  • [4] Estrogen receptor target gene: An evolving concept
    Carroll, Jason S.
    Brown, Myles
    [J]. MOLECULAR ENDOCRINOLOGY, 2006, 20 (08) : 1707 - 1714
  • [5] Estrogen Receptor α Controls a Gene Network in Luminal-Like Breast Cancer Cells Comprising Multiple Transcription Factors and MicroRNAs
    Cicatiello, Luigi
    Mutarelli, Margherita
    Grober, Ohi M. V.
    Paris, Ornella
    Ferraro, Lorenzo
    Ravo, Maria
    Tarallo, Roberta
    Luo, Shujun
    Schroth, Gary P.
    Seifert, Martin
    Zinser, Christian
    Chiusano, Maria Luisa
    Traini, Alessandra
    De Bortoli, Michele
    Weisz, Alessandro
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) : 2113 - 2130
  • [6] Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer
    Dowsett, M
    [J]. ENDOCRINE-RELATED CANCER, 2001, 8 (03) : 191 - 195
  • [7] An oestrogen-receptor-α-bound human chromatin interactome
    Fullwood, Melissa J.
    Liu, Mei Hui
    Pan, You Fu
    Liu, Jun
    Xu, Han
    Bin Mohamed, Yusoff
    Orlov, Yuriy L.
    Velkov, Stoyan
    Ho, Andrea
    Mei, Poh Huay
    Chew, Elaine G. Y.
    Huang, Phillips Yao Hui
    Welboren, Willem-Jan
    Han, Yuyuan
    Ooi, Hong Sain
    Ariyaratne, Pramila N.
    Vega, Vinsensius B.
    Luo, Yanquan
    Tan, Peck Yean
    Choy, Pei Ye
    Wansa, K. D. Senali Abayratna
    Zhao, Bing
    Lim, Kar Sian
    Leow, Shi Chi
    Yow, Jit Sin
    Joseph, Roy
    Li, Haixia
    Desai, Kartiki V.
    Thomsen, Jane S.
    Lee, Yew Kok
    Karuturi, R. Krishna Murthy
    Herve, Thoreau
    Bourque, Guillaume
    Stunnenberg, Hendrik G.
    Ruan, Xiaoan
    Cacheux-Rataboul, Valere
    Sung, Wing-Kin
    Liu, Edison T.
    Wei, Chia-Lin
    Cheung, Edwin
    Ruan, Yijun
    [J]. NATURE, 2009, 462 (7269) : 58 - 64
  • [8] A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells
    Hah, Nasun
    Danko, Charles G.
    Core, Leighton
    Waterfall, Joshua J.
    Siepel, Adam
    Lis, John T.
    Kraus, W. Lee
    [J]. CELL, 2011, 145 (04) : 622 - 634
  • [9] FOXA1 is a key determinant of estrogen receptor function and endocrine response
    Hurtado, Antoni
    Holmes, Kelly A.
    Ross-Innes, Caryn S.
    Schmidt, Dominic
    Carroll, Jason S.
    [J]. NATURE GENETICS, 2011, 43 (01) : 27 - U42
  • [10] Endocrine-resistant breast cancer: Underlying mechanisms and strategies for overcoming resistance
    Junichi Kurebayashi
    [J]. Breast Cancer, 2003, 10 (2) : 112 - 119
123